Skip to content

Trinity Biotech HbA1c (GHb) Controls Kit, 500uL (Levels I & II) - 1 kitRecalls & reported problems

Primus Corporation · Hemoglobin A1c assay, HbA1c (GHb) Controls Kit, 500uL (Levels I & II) - 1 kit · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05391516748087), received between Nov 16, 2021 and Nov 16, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Unable to Obtain Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unable to Obtain Readings1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 16, 2021Unable to Obtain Readings; Unable to Obtain Readings

    HBA1C CONTROL I OF LOT 12160 OBSERVED WITH VALUES ABOVE THE ACCEPTABLE TARGET RANGE. VENDOR IDENTIFIED AN UNCOMMONLY HIGH GLUCOSE LEVEL IN THE CONTROL MATERIAL WHICH GLYCATES OVER TIME CREATED FALSE HIGH VALUES. PRODUCT LOT HAD BEEN PLACED ON SHIPPING HOLD NEAR THE SAME TIME AS THE COMPLAINT. NO KNOWN REPORTING TO MEDICAL STAFF OR PATIENTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12819907 ↗

Other Mixture, Hematology Quality Control devices

All Mixture, Hematology Quality Control devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page